PMID- 23335033 OWN - NLM STAT- MEDLINE DCOM- 20140110 LR - 20211021 IS - 1559-1166 (Electronic) IS - 0895-8696 (Linking) VI - 50 IP - 3 DP - 2013 Jul TI - Oxytocin receptor ligands induce changes in cytoskeleton in neuroblastoma cells. PG - 462-8 LID - 10.1007/s12031-013-9960-4 [doi] AB - Aim of the present study was to evaluate effects of ligands of oxytocin receptors on gene expression of neurofilament proteins (nestin and microtubule-associated protein 2 (MAP2)) associated with neuronal differentiation and growth factors (brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF)) related to neuronal growth. Fluorescent staining of F-actin was used to observe morphology of cells. Co-treatment with oxytocin and oxytocin receptor antagonist--atosiban--resulted in significant increase of MAP2 gene expression in SK-N-SH cells. There was no effect of oxytocin on gene expression of growth factors BDNF and NGF. Surprisingly, oxytocin with atosiban significantly increased mRNA levels for both BDNF and NGF. Gene expression of vasopressin receptor (V1aR) significantly decreased in response to vasopressin. Atosiban decreased mRNA levels for oxytocin receptor (OXTR) and V1aR. Oxytocin significantly decreased OXTR and nestin mRNA levels and increased mRNA levels for BDNF and NGF in U-87 MG cells. The densest recruitment of F-actin filaments was observed in apical parts of filopodia in SK-N-SH cells incubated in oxytocin presence. Present data demonstrate complex role of ligands of oxytocin receptors in regulation of gene expression of intermediate filaments and thus, oxytocin might be considered as a growth factor in neuronal type of cells. FAU - Bakos, Jan AU - Bakos J AD - Institute of Experimental Endocrinology, Slovak Academy of Sciences, Vlarska 3, Bratislava, Slovakia. j.bakos@savba.sk FAU - Strbak, Vladimir AU - Strbak V FAU - Paulikova, Helena AU - Paulikova H FAU - Krajnakova, Lucia AU - Krajnakova L FAU - Lestanova, Zuzana AU - Lestanova Z FAU - Bacova, Zuzana AU - Bacova Z LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20130120 PL - United States TA - J Mol Neurosci JT - Journal of molecular neuroscience : MN JID - 9002991 RN - 0 (Actins) RN - 0 (Brain-Derived Neurotrophic Factor) RN - 0 (Ligands) RN - 0 (MAP2 protein, human) RN - 0 (Microtubule-Associated Proteins) RN - 0 (NES protein, human) RN - 0 (Nestin) RN - 0 (Receptors, Oxytocin) RN - 0 (Receptors, Vasopressin) RN - 081D12SI0Z (atosiban) RN - 50-56-6 (Oxytocin) RN - 9061-61-4 (Nerve Growth Factor) RN - W6S6URY8OF (Vasotocin) SB - IM MH - Actin Cytoskeleton/*drug effects/ultrastructure MH - Actins/genetics/metabolism MH - Brain-Derived Neurotrophic Factor/genetics/metabolism MH - Cell Line, Tumor MH - Humans MH - Ligands MH - Microtubule-Associated Proteins/genetics/metabolism MH - Nerve Growth Factor/genetics/metabolism MH - Nestin/genetics/metabolism MH - Neuroblastoma MH - Neurons/*ultrastructure MH - Oxytocin/*pharmacology MH - Receptors, Oxytocin/genetics/*metabolism MH - Receptors, Vasopressin/genetics/metabolism MH - Transcription, Genetic/drug effects MH - Vasotocin/analogs & derivatives/pharmacology EDAT- 2013/01/22 06:00 MHDA- 2014/01/11 06:00 CRDT- 2013/01/22 06:00 PHST- 2012/11/15 00:00 [received] PHST- 2013/01/10 00:00 [accepted] PHST- 2013/01/22 06:00 [entrez] PHST- 2013/01/22 06:00 [pubmed] PHST- 2014/01/11 06:00 [medline] AID - 10.1007/s12031-013-9960-4 [doi] PST - ppublish SO - J Mol Neurosci. 2013 Jul;50(3):462-8. doi: 10.1007/s12031-013-9960-4. Epub 2013 Jan 20.